Daclizumab Subcutaneous and Lidocaine Topical Oral Solution 4%
Determining the interaction of Daclizumab Subcutaneous and Lidocaine Topical Oral Solution 4% and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: lidocaine
Brand name: UAD Caine, Xylocaine HCl, Xylocaine-MPF, Lidoject 1, Xylocaine Dental Cartridges, Lidoject 2, Xylocaine Duo-Trach Kit, Xylocaine HCl For Spinal, L-Caine, Dilocaine, Nervocaine, Truxacaine, Anestacaine
Synonyms: Lidocaine injection, Lidocaine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Lidocaine Topical System
- Daclizumab Subcutaneous-Lidocaine viscous
- Daclizumab Subcutaneous-LidoCort
- Daclizumab Subcutaneous-Lidoderm
- Daclizumab Subcutaneous-Lidoderm Topical application
- Daclizumab Subcutaneous-Lidodextrapine
- Lidocaine Topical Oral Solution 4%-Dacogen
- Lidocaine Topical Oral Solution 4%-Dacomitinib
- Lidocaine Topical Oral Solution 4%-Dactinomycin
- Lidocaine Topical Oral Solution 4%-Dactinomycin Injection
- Lidocaine Topical Oral Solution 4%-Dactinomycin Intravenous
- Lidocaine Topical Oral Solution 4%-Daklinza